KR880006244A - 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법 - Google Patents

3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법

Info

Publication number
KR880006244A
KR880006244A KR860013220A KR860013220A KR880006244A KR 880006244 A KR880006244 A KR 880006244A KR 860013220 A KR860013220 A KR 860013220A KR 860013220 A KR860013220 A KR 860013220A KR 880006244 A KR880006244 A KR 880006244A
Authority
KR
South Korea
Prior art keywords
compound
formula
salt
alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR860013220A
Other languages
English (en)
Korean (ko)
Inventor
마사요시 무라다
히데오 쓰쯔미
게이지 마쯔다
고지 하또리
다까시 나까지마
Original Assignee
후지사와 도모 기찌 로
후지사와 야꾸힝 고오교오 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후지사와 도모 기찌 로, 후지사와 야꾸힝 고오교오 가부시기가이샤 filed Critical 후지사와 도모 기찌 로
Priority claimed from GB868628063A external-priority patent/GB8628063D0/en
Priority claimed from GB868631081A external-priority patent/GB8631081D0/en
Priority claimed from GB878709399A external-priority patent/GB8709399D0/en
Priority claimed from GB878716937A external-priority patent/GB8716937D0/en
Publication of KR880006244A publication Critical patent/KR880006244A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR860013220A 1986-11-24 1986-11-23 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법 Pending KR880006244A (ko)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB868628063A GB8628063D0 (en) 1986-11-24 1986-11-24 Carboxylic acid compounds
JP8628063 1986-11-24
GB868631081A GB8631081D0 (en) 1986-12-31 1986-12-31 3-pyrrolidinylthio-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds
JP8631081 1986-12-31
GB878709399A GB8709399D0 (en) 1987-04-21 1987-04-21 Carboxylic acid compounds
JP8709399 1987-04-21
JP8716937 1987-07-17
GB878716937A GB8716937D0 (en) 1987-07-17 1987-07-17 Carboxylic acid compounds

Publications (1)

Publication Number Publication Date
KR880006244A true KR880006244A (ko) 1988-07-22

Family

ID=27449846

Family Applications (2)

Application Number Title Priority Date Filing Date
KR860013220A Pending KR880006244A (ko) 1986-11-24 1986-11-23 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
KR1019870013221A Ceased KR880006245A (ko) 1986-11-24 1987-11-23 3- 피롤리디닐티오-1- 아자바이시클로[3.2.0]헵트-2-엔-2-카르복실산유도체 및 이의 제조방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019870013221A Ceased KR880006245A (ko) 1986-11-24 1987-11-23 3- 피롤리디닐티오-1- 아자바이시클로[3.2.0]헵트-2-엔-2-카르복실산유도체 및 이의 제조방법

Country Status (17)

Country Link
US (3) US4822787A (cg-RX-API-DMAC10.html)
EP (2) EP0280771B1 (cg-RX-API-DMAC10.html)
JP (2) JP2555647B2 (cg-RX-API-DMAC10.html)
KR (2) KR880006244A (cg-RX-API-DMAC10.html)
CN (1) CN87107938A (cg-RX-API-DMAC10.html)
AU (1) AU599439B2 (cg-RX-API-DMAC10.html)
DE (2) DE3786781T2 (cg-RX-API-DMAC10.html)
DK (1) DK594687A (cg-RX-API-DMAC10.html)
ES (2) ES2058091T3 (cg-RX-API-DMAC10.html)
FI (1) FI875135L (cg-RX-API-DMAC10.html)
GR (1) GR3007651T3 (cg-RX-API-DMAC10.html)
HU (1) HU201762B (cg-RX-API-DMAC10.html)
IL (1) IL84446A0 (cg-RX-API-DMAC10.html)
NO (1) NO874869L (cg-RX-API-DMAC10.html)
NZ (1) NZ222634A (cg-RX-API-DMAC10.html)
OA (1) OA08694A (cg-RX-API-DMAC10.html)
PT (1) PT86182B (cg-RX-API-DMAC10.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880006244A (ko) * 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
US4925838A (en) * 1988-03-18 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
GB8811237D0 (en) * 1988-05-12 1988-06-15 Fujisawa Pharmaceutical Co 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
TW198034B (cg-RX-API-DMAC10.html) * 1990-03-27 1993-01-11 Manyu Seiyaku Kk
CA2050255C (en) * 1990-09-07 1997-02-04 Tameo Iwasaki 1-methylcarbapenem derivatives and process for preparation thereof
US5208348A (en) * 1990-09-07 1993-05-04 Tanabe Seiyaku Co., Ltd. Mercaptan compound
GB9107342D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
JP3048196B2 (ja) * 1991-06-20 2000-06-05 第一製薬株式会社 カルバペネム誘導体
US5360798A (en) * 1991-07-04 1994-11-01 Shionogi Seiyaku Kabushiki Kaisha Aminooxypyrrolidinylthiocarbapenem compounds
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
US5608056A (en) * 1992-04-13 1997-03-04 Fujisawa Pharmaceutical Co., Ltd. Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents
JP2783683B2 (ja) * 1992-12-21 1998-08-06 ジョン グン ダン コーポレーション 2−(2−置換されたピロリジン−4−イル)チオ−カバペネム誘導体
JP3848693B2 (ja) * 1994-07-06 2006-11-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規カルバペネム誘導体
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
AU4020897A (en) 1996-08-17 1998-03-06 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
EP0937079A4 (en) * 1996-10-28 2001-01-24 Merck & Co Inc STABILIZED ANTIBIOTIC CARBAPENEM COMPOSITIONS AND A METHOD FOR THEIR PRODUCTION
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
US6476698B1 (en) 2000-03-17 2002-11-05 General Electric Company Convertible locking arrangement on breakers
KR100385093B1 (ko) * 2000-08-25 2003-05-22 한국과학기술연구원 5'-헤테로아릴티오메틸피롤리딘-3'-일티오기를 갖는 신규 1-베타메틸카바페넴 유도체 및 그의 제조방법
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
JP6484555B2 (ja) 2013-08-29 2019-03-13 京都薬品工業株式会社 新規芳香族化合物およびその用途
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
JP2019056421A (ja) * 2017-09-21 2019-04-11 日本電産トーソク株式会社 電磁弁

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
US4428960A (en) * 1982-04-19 1984-01-31 Merck & Co., Inc. 3-Amino-6-substituted thio-1-azabicyclo(3.2.0)hept-6-en-2-one-7-carboxylic acids
JPS5916892A (ja) * 1982-07-19 1984-01-28 Sankyo Co Ltd カルバペネム−3−カルボン酸誘導体およびその製法
KR900006449B1 (ko) * 1982-08-24 1990-08-31 상꾜 가부시끼가이샤 아제티디논 화합물의 제조방법
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd 1―置換カルバペネム―3―カルボン酸誘導体
DE3579888D1 (de) * 1984-11-08 1990-10-31 Sumitomo Pharma Carbapenemverbindungen und deren herstellung.
DE3780344T2 (de) * 1986-03-27 1993-01-28 Sumitomo Pharma Beta-lactam-verbindungen und deren herstellung.
IE60588B1 (en) * 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
KR880006244A (ko) * 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법

Also Published As

Publication number Publication date
HU201762B (en) 1990-12-28
EP0272456B1 (en) 1993-03-31
EP0272456A1 (en) 1988-06-29
US5061804A (en) 1991-10-29
ES2058091T3 (es) 1994-11-01
FI875135A7 (fi) 1988-05-25
FI875135A0 (fi) 1987-11-20
AU8150087A (en) 1988-05-26
IL84446A0 (en) 1988-04-29
KR880006245A (ko) 1988-07-22
DE3785163T2 (de) 1993-07-29
DE3785163D1 (de) 1993-05-06
JPS63179876A (ja) 1988-07-23
PT86182A (en) 1987-12-01
FI875135L (fi) 1988-05-25
DK594687D0 (da) 1987-11-12
ES2053509T3 (es) 1994-08-01
NZ222634A (en) 1990-06-26
HUT45530A (en) 1988-07-28
CN87107938A (zh) 1988-08-10
NO874869L (no) 1988-05-25
DK594687A (da) 1988-05-25
JPS63179875A (ja) 1988-07-23
NO874869D0 (no) 1987-11-23
AU599439B2 (en) 1990-07-19
JP2512968B2 (ja) 1996-07-03
DE3786781T2 (de) 1993-11-25
PT86182B (pt) 1990-11-07
US4963543A (en) 1990-10-16
GR3007651T3 (cg-RX-API-DMAC10.html) 1993-08-31
EP0280771B1 (en) 1993-07-28
DE3786781D1 (de) 1993-09-02
JP2555647B2 (ja) 1996-11-20
EP0280771A1 (en) 1988-09-07
OA08694A (fr) 1989-03-31
US4822787A (en) 1989-04-18

Similar Documents

Publication Publication Date Title
KR880006245A (ko) 3- 피롤리디닐티오-1- 아자바이시클로[3.2.0]헵트-2-엔-2-카르복실산유도체 및 이의 제조방법
US4260543A (en) Crystalline N-formimidoyl thienamycin
GEP20001940B (en) Valaciclovir Hydrochloride in Essentially Anhydrous Crystalline Form, Processes for its Producing, Use and Method of Treatment
DE68917023D1 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen.
KR890016045A (ko) 2-(헤테로시클릴티오)카르바페넴 유도체, 그의 제조방법 및 항생제로서의 그의 용도
KR910009712A (ko) 세펨 화합물 및 이의 제조방법
JP2003513889A (ja) ノイラミニダーゼの阻害剤
MA26457A1 (fr) Vinylpyrrolidone-cephalosporines a substituants basiques, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
KR880012604A (ko) (1r,5s,6s )-2-치환 티오-6[(r)-1-히드록시에틸]-1-메틸-카바페넴-3-카복실산 유도체
KR880001677A (ko) β-락탐 화합물, 그의 제조 방법, 이를 함유하는 세균 감염성 질병 치료용 약제 및 그의 합성을 위한 중간체
RU94046013A (ru) Способ получения (s)-3-амино-1-замещенного пирролидина, промежуточные продукты для их синтеза и промежуточный продукт для синтеза антибактериальных агентов на основе хинолона
KR910700230A (ko) 신규 히드록실아민 유도체
DE69930616D1 (de) Verfahren zur synthese von carbapenem-antibiotika
IE48356B1 (en) Crystalline n-formimidoyl thienamycin
RU98119310A (ru) 1-метилкарбапенем или его фармакологически приемлемые соли или производные, композиция, способ предупреждения или лечения бактериальных инфекций
KR930002350A (ko) 아미노옥시피롤리디닐티오카르바페넴 화합물
RU2091381C1 (ru) Производные карбапенема и их фармацевтически приемлемые соли
KR890003779A (ko) β-락탐 화합물, 이 화합물의 제조방법, 이 화합물의 합성용 중간체 및 이 화합물을 함유하는 세균감염 질환 치료용 의약조성물
GB1470154A (en) Dialkylaminoalkyl esters of penicillin and process for the preparation thereof
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
KR900018097A (ko) 3-피롤리디닐티오 1-아자비시클로[3.2.0]-헵트-2-엔-2-카르복실산 유도체 및 그의 제조방법
KR870004984A (ko) 카르바모일옥시메틸 알킬카르바페넴 화합물
KR930703322A (ko) 아미노알킬피롤리디닐티오카르바페넴 유도체
US3474089A (en) Substituted adamantyl penicillins
KR880001667A (ko) 비사이클릭 티아아자 화합물